Biobanking Market by Product Type, Distribution Channel, End User 2022-2027

Author: Elena Anderson

Marketing Manager

Report DescriptionAbout IMARC Group

International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

Global Biobanking Market Research Report 2022-2027:

According to the latest report by IMARC Group, titled " Biobanking Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-20 27

," the global biobanking market size reached US$ 53.3 Billion in 2021.

Biobanking refers to the procedure of collecting and preserving human biospecimens that can be further used for diagnosis, biodiversity studies, and research. These specimens are stored for several years and are used by multiple researchers for cross-purpose research studies and to improve the understanding of health and different diseases. Over the years, biobanking has become a vital resource in medical research, supporting various types of contemporary research like genomics and personalized medicine.

Request for a PDF sample of this report:

https://www.imarcgroup.com/biobanking-market/requestsample

Global Biobanking Market Trends:

The market is primarily driven by the growing prevalence of infectious and chronic diseases as biobanking is extensively used to develop diagnostics that can accurately and quickly identify pathogens. In addition, the escalating demand for regenerative medicine and personalized treatment represents another major growth-inducing factor. Besides this, health agencies of numerous countries are investing in virtual biobank network models that help investigators locate biospecimens and data mining from multiple biobanks. This, coupled with the significant developments in genomics, disease biology, metagenomics, proteomics, bioenergy, and environmental remediation, are positively influencing the market growth. Moreover, key players are integrating various advanced technologies with biobanking that assists healthcare professionals in collecting high-quality and well-annotated human biospecimens, and understanding pathogenic mechanisms. These advanced methods are also being utilized to identify therapeutic targets of coronavirus disease (COVID-19), which is also creating a positive market outlook across the globe.

Looking forward, IMARC Group expects the market to reach US$ 77.6 Billion by 2027, expanding at a CAGR of 6.18% during the forecast period (2022-2027).

View Report TOC, Figures and Tables: https://www.imarcgroup.com/biobanking-market

Report Description Report Description and Highlights

Key Market Segmentation

The research report includes the following segments:

Breakup by Specimen Type:

• Blood Products

• Solid Tissue

• Cell Lines

• Nucleic Acid

• Others

Breakup by Biobank Type:

• Population-based Biobanks

• Disease-oriented Biobanks

Breakup by Application:

• Therapeutics

• Research

Report Description Report Description and Highlights

Breakup by End User:

• Academic Institutions

• Pharma and Biotech Companies

Breakup by Region:

• North America

• Asia Pacific

• Europe

• Latin America

• Middle East and Africa

Competitive Landscape with Key Players:

• Brooks Automation Inc

• Bay Biosciences LLC

• Boca Biolistics

• Ctibiotech

• Cureline Inc

• Firalis

• Greiner Bio-One International GmbH

• Hamilton Company

• Merck KGaA

• ProteoGenex Inc

• Thermo Fisher Scientific Inc

• VWR Corporation (Avantor Inc.)

1. What was the size of the global biobanking market in 2021?

2. What is the expected growth rate of the global biobanking market during 2022-2027?

3. What are the key factors driving the global biobanking market?

4. What has been the impact of COVID-19 on the global biobanking market?

5. What is the breakup of the global biobanking market based on the specimen type?

6. What is the breakup of the global biobanking market based on the biobank type?

7. What is the breakup of the global biobanking market based on the application?

8. What is the breakup of the global biobanking market based on the end user?

9. What are the key regions in the global biobanking market?

10. Who are the key players/companies in the global biobanking market?

Click here to visit the complete table of content with list of figures and tables: https://www.imarcgroup.com/biobanking-market/toc

A partial List of our Clients

Partial List of Clients

We are the trusted business partners to the world's leading corporates, governments, and institutions

A partial List of our Clients

Partial List of Clients

We are the trusted business partners to the world's leading corporates, governments, and institutions

Report Description Report Description and Highlights

© 2022 IMARC All Rights Reserved

This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).

Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.

IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.